$MYO Income Statement | Understand Stock

$MYO

$1.20 -$0.01 (0.83%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product Revenue
License Revenue
Total revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Selling, clinical, and marketing
General and administrative
Total operating expenses
Loss from operations
Other expense (income)
Other expense (income)
Other expense, net
Loss on equity investment
Total other expense (income)

Loss before income taxes
Income tax expense
Net loss
Deemed dividend on discounting and repricing of warrants
Net loss attributable to common stockholders
Basic and diluted
Earnings Per Share, Basic
Weighted average number of common shares outstanding:
Basic
Diluted
Net loss per share available to common stockholders:
Basic
Diluted

Comments